iv glutathione sydney Face of Man How Glutathione IV Therapy Supports

Compared to NSAIDs: No gastrointestinal toxicity No cardiac risks No kidney damage risk No drug interactions Actively promotes healing rather than masking symptoms Compared to corticosteroids: No immunosuppression No bone density loss No endocrine disruption No adrenal suppression Promotes healing rather than suppressing inflammation Compared to other peptides: Similar or better safety profile Minimal side effects No hormonal disruption Well tolerated across populations Regulatory and Ethical Considerations Researchers should be aware of the regulatory status

This maintenance phase is key to keeping the benefits from the first phase

In cancer patients, intestinal malabsorption (i.e., surgical procedures involving the stomach and duodenum, short bowel syndrome, liver failure), diarrhea and intestinal fistulas, and total parenteral nutrition are all conditions associated with a higher risk of deficiency

These studies used doses ranging from 1 mg per day to 30 mg per day administered through various routes (subcutaneous, oral, and intranasal)